Markets:

Overview

News

Currencies

International

Treasuries

Humacyte, Inc. - Common Stock (NQ:HUMA)

0.5173 -0.0127 (-2.40%)

Streaming Delayed Price Updated: 2:25 PM EDT, Sep 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Humacyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Humacyte (HUMA) Q2 2026 Earnings Call Transcript ↗

August 19, 2026

Phase III trial shows 91 more catheter-free days for dialysis patients.

Via The Motley Fool

Topics Earnings

Humacyte Q2 Earnings Call Highlights ↗

August 12, 2026

Humacyte (NASDAQ:HUMA) reported second-quarter commercial sales growth while outlining plans to expand adoption of its SYMVESS vascular repair product, submit a supplemental biologics license...

Via MarketBeat

Topics Earnings

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 01, 2026

Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million. Humacyte (NASDAQ:HUMA) shares moved upwards by 5.45% to...

Via Benzinga

Wondering what's happening in today's pre-market session? ↗

June 11, 2026

Via Chartmill

Humacyte Inc (NASDAQ:HUMA) Reports Q4 Revenue Miss, Shares Drop Pre-Market ↗

March 27, 2026

Via Chartmill

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

Get insights into the top gainers and losers of Wednesday's after-hours session. ↗

June 10, 2026

Via Chartmill

Humacyte (HUMA) Q1 2025 Earnings Transcript ↗

June 01, 2026

Humacyte (HUMA) Q1 2025 Earnings Transcript

Via The Motley Fool

Humacyte (HUMA) Q1 2026 Earnings Transcript ↗

May 13, 2026

Humacyte (HUMA) Q1 2026 Earnings Transcript

Via The Motley Fool

Humacyte Q1 Earnings Call Highlights ↗

May 13, 2026

Humacyte (NASDAQ:HUMA) reported first-quarter 2026 Symvess sales of $0.5 million and outlined a series of commercial, clinical and cost-reduction initiatives aimed at accelerating adoption of its...

Via MarketBeat

Topics Earnings

The market is filled with gapping stocks in Monday's session. ↗

February 09, 2026

Via Chartmill

HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗

February 09, 2026

The company stated that its product, Symvess, is the only human-derived bioengineered blood vessel approved by the U.S. Food and Drug Administration.

Via Stocktwits

Humacyte (HUMA) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Humacyte (HUMA) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Death Earnings

Humacyte Inc (NASDAQ:HUMA) Beats on EPS but Misses on Revenue in Q3 ↗

November 12, 2025

Humacyte (HUMA) missed Q3 revenue estimates but delivered a smaller-than-expected loss per share. The stock rose as investors focused on its pipeline progress toward key regulatory milestones.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 12, 2025

Via Benzinga

Insights Ahead: Humacyte's Quarterly Earnings ↗

November 11, 2025

Via Benzinga

Top stock movements in today's session. ↗

October 07, 2025

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 07, 2025

Via Benzinga

Which stocks are moving on Tuesday? ↗

October 07, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Tuesday's session: gap up and gap down stocks ↗

October 07, 2025

The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 03, 2025

Via Benzinga

Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback ↗

September 18, 2025

Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Small caps rally 43% since tariff-driven selloff.

Via Benzinga

Topics ETFs Economy

Which stocks are experiencing notable movement on Monday? ↗

August 11, 2025

Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 11, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

August 11, 2025

Here are the top movers in Monday's session, showcasing the stocks with significant price changes.

Via Chartmill

Monday's session: gap up and gap down stocks ↗

August 11, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Humacyte Inc (NASDAQ:HUMA) Q2 2025 Earnings: Revenue Misses Estimates, Shares Drop 9.9% in Pre-Market ↗

August 11, 2025

Humacyte Inc (HUMA) Q2 2025 earnings show a revenue miss of 70%, with shares dropping ~9.9% pre-market. Hospital approvals grow, but commercial adoption lags.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 11, 2025

Via Benzinga

Humacyte Posts Q2 Revenue Miss ↗

August 11, 2025

Via The Motley Fool

Topics Intellectual Property

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Humacyte, Inc. - Common Stock (NQ:HUMA)

Headline News about Humacyte, Inc. - Common Stock

Starting at /week.